Last reviewed · How we verify
Collection of stool samples
Collection of stool samples is used to diagnose and monitor gastrointestinal diseases.
Collection of stool samples is used to diagnose and monitor gastrointestinal diseases. Used for Diagnosis and monitoring of gastrointestinal diseases.
At a glance
| Generic name | Collection of stool samples |
|---|---|
| Also known as | Nivolumab, Ipilimumab, Atezolizumab |
| Sponsor | Ardigen |
| Modality | Biologic |
| Therapeutic area | Gastroenterology |
| Phase | Phase 2 |
Mechanism of action
This involves analyzing the composition and characteristics of stool to identify potential biomarkers for various conditions. The process can help healthcare professionals diagnose and monitor diseases such as inflammatory bowel disease, irritable bowel syndrome, and gastrointestinal infections.
Approved indications
- Diagnosis and monitoring of gastrointestinal diseases
Common side effects
Key clinical trials
- Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer (PHASE1)
- Neoadjuvant Regorafenib in Combination With Nivolumab and Short-course Radiotherapy in Stage II-III Rectal Cancer (PHASE2)
- Aspirin in Preventing Colorectal Cancer in Patients With Colorectal Adenoma (PHASE2)
- Blood Donor CVD 5000 (PHASE4)
- Study of the Immunological and Virological Response of Patients With COVID-19 and Presenting an Asymptomatic or Pauci-symptomatic Form (AMBUCOV) (NA)
- MIMICC Study in Patients With Colorectal Cancer (NA)
- Collection of Data and Samples From Healthy Donors for Use in Translational Research
- Construction and Evaluation of Tumor Immunotherapy and Organ Damage Early Warning System Based on Multi-omics
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Collection of stool samples CI brief — competitive landscape report
- Collection of stool samples updates RSS · CI watch RSS
- Ardigen portfolio CI